Texas Capital Bancshares Inc/Tx (TCBIO) Payables (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Payables for 17 consecutive years, with $28.9 billion the latest figure, recorded in Q2 2026.

• Quarterly Payables rose 10.92% year-over-year to $28.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $28.9 billion (up 10.92% YoY) and the FY2025 annual result came in at $26.4 billion, up 4.79% from the prior year.
• Payables climbed to $28.9 billion in Q2 2026 per TCBIO's latest filing, from $28.5 billion in the prior quarter.
• Over the last five years, Payables for TCBIO reached as high as $28.9 billion in Q2 2026 and fell as low as $22.2 billion in Q1 2023.
• A 5-year average of $25.1 billion and a median of $25.3 billion in 2022 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables declined 24.0% — and 2024, when it rose 12.81%.
• Year by year, Payables stood at $22.9 billion in 2022, then declined by 2.12% to $22.4 billion in 2023, then increased by 12.81% to $25.2 billion in 2024, then grew by 4.79% to $26.4 billion in 2025, then advanced by 9.31% to $28.9 billion in 2026.
• According to Business Quant data, Payables over the past three periods registered $28.9 billion, $28.5 billion, and $26.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.